Literature DB >> 29339177

Trends in reporting histological subtyping of renal cell carcinoma: association with cancer center type.

Ted Gansler1, Stacey Fedewa2, Mahul B Amin3, Chun Chieh Lin4, Ahmedin Jemal5.   

Abstract

Histological classification of renal cell carcinoma (RCC) has become increasingly important for clinical management. We identified 295483 RCC diagnosed from 1998-2014 in the National Cancer Database (NCDB) to examine temporal trends in proportions of RCC with unspecified histology and several specific histologies from the 1998 and 2004 World Health Organization classifications of RCC. Further, multivariable log binomial analysis of 101062 RCC diagnosed from 2010 to 2014 was used to determine whether the association of diagnosing/treating facility type and the proportion of unspecified RCC is independent of patient demographic and clinical factors. Between 1998 and 2014, the proportion of histologically unspecified RCC decreased substantially in all facility types, with the decrease smallest in community programs (from 86.0% to 28.1%) and largest in National Cancer Institute-designated centers (from 85.1% to 9.8%). These decreases were offset by increases in percentages of papillary, clear cell, and chromophobe RCC cases. During 2010 to 2014, relative to community programs, RCCs were 21% less likely to be reported as unspecified histology (adjusted prevalence ratio [aPR] = 0.79; 95% CI, 0.68-0.92) in comprehensive community programs, 32% less likely in integrated network programs (aPR = 0.68; 95% CI, 0.57-0.92) and academic programs (aPR = 0.68; 95% CI, 0.54-0.87), and 63% less likely (aPR = 0.37; 95% CI, 0.26-0.52) in National Cancer Institute -designated programs. These results have implications for the optimal selection of targeted systemic therapies for patients with advanced disease, and for the potential value of cancer registry data in pathology quality improvement programs to promote more rapid and consistent adoption of new classifications of RCC and other neoplasms.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Classification; Healthcare quality; Pathology; Registries; Renal cell carcinoma

Mesh:

Year:  2018        PMID: 29339177     DOI: 10.1016/j.humpath.2018.01.010

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Evaluation of Renal Function after Partial Nephrectomy and Detection of Clinically Significant Acute Kidney Injury.

Authors:  Jurijus Makevičius; Albertas Čekauskas; Arūnas Želvys; Albertas Ulys; Feliksas Jankevičius; Marius Miglinas
Journal:  Medicina (Kaunas)       Date:  2022-05-17       Impact factor: 2.948

2.  Trends and projections of kidney cancer incidence at the global and national levels, 1990-2030: a Bayesian age-period-cohort modeling study.

Authors:  Zhebin Du; Wei Chen; Qier Xia; Oumin Shi; Qi Chen
Journal:  Biomark Res       Date:  2020-05-13

3.  The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort.

Authors:  Tobias Klatte; Kevin M Gallagher; Luca Afferi; Alessandro Volpe; Nils Kroeger; Silvia Ribback; Alan McNeill; Antony C P Riddick; James N Armitage; Tevita F 'Aho; Tim Eisen; Kate Fife; Axel Bex; Allan J Pantuck; Grant D Stewart
Journal:  BMC Med       Date:  2019-10-03       Impact factor: 8.775

4.  Mycotoxin Exposure and Renal Cell Carcinoma Risk: An Association Study in the EPIC European Cohort.

Authors:  Liesel Claeys; Sarah De Saeger; Ghislaine Scelo; Carine Biessy; Corinne Casagrande; Genevieve Nicolas; Michael Korenjak; Beatrice Fervers; Alicia K Heath; Vittorio Krogh; Leila Luján-Barroso; Jesús Castilla; Börje Ljungberg; Miguel Rodriguez-Barranco; Ulrika Ericson; Carmen Santiuste; Alberto Catalano; Kim Overvad; Magritt Brustad; Marc J Gunter; Jiri Zavadil; Marthe De Boevre; Inge Huybrechts
Journal:  Nutrients       Date:  2022-08-30       Impact factor: 6.706

5.  Dietary Patterns in Italy and the Risk of Renal Cell Carcinoma.

Authors:  Michela Dalmartello; Francesca Bravi; Diego Serraino; Anna Crispo; Monica Ferraroni; Carlo La Vecchia; Valeria Edefonti
Journal:  Nutrients       Date:  2020-01-02       Impact factor: 5.717

Review 6.  Epidemiology and Risk Factors for Kidney Cancer.

Authors:  Ghislaine Scelo; Tricia L Larose
Journal:  J Clin Oncol       Date:  2018-10-29       Impact factor: 44.544

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.